Insider Stock Trading History of Clancy Paul J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Clancy Paul J since year 2005. The trader's CIK number is 1409601. At the time of this reporting, Clancy Paul J is the EVP, Chief Financial Officer of Alexion Pharmaceuticals Inc . (stock ticker symbol ALXN). See this page for all insider trading activities at Alexion Pharmaceuticals Inc .

Note that in the past Clancy Paul J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Clancy Paul J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-02-08 ALXN Alexion Pharmaceuticals Inc Sale 6,079 116.31 707,048
2017-04-25 BIIB Biogen Inc. Sale 9,892 290.00 2,868,680
2017-03-13 BIIB Biogen Inc. Sale 9,891 291.55 2,883,721
2017-02-28 BIIB Biogen Inc. Option Ex 6,780 .00 0
2016-02-12 BIIB Biogen Inc. Option Ex 3,859 .00 0
2015-02-12 BIIB Biogen Inc. Option Ex 4,299 .00 0
2015-02-08 BIIB Biogen Inc. Option Ex 3,191 .00 0
2015-02-09 BIIB Biogen Inc. Option Ex 4,691 .00 0
2014-02-23 BIIB Biogen Inc. Option Ex 4,280 .00 0
2014-02-12 BIIB Biogen Inc. Option Ex 2,807 .00 0
2014-02-08 BIIB Biogen Inc. Option Ex 3,191 .00 0
2014-02-09 BIIB Biogen Inc. Option Ex 4,691 .00 0
2013-09-18 BIIB Biogen Inc. Option Ex 26,785 49.65 1,329,875
2013-09-18 BIIB Biogen Inc. Sale 26,785 245.00 6,562,325
2013-09-16 BIIB Biogen Inc. Option Ex 99,030 51.74 5,123,614
2013-09-16 BIIB Biogen Inc. Sale 99,030 238.47 23,615,882
2013-04-29 BIIB Biogen Inc. Sale 9,123 219.71 2,004,414
2013-04-30 BIIB Biogen Inc. Sale 14,489 224.58 3,253,925
2013-02-23 BIIB Biogen Inc. Option Ex 4,281 .00 0
2013-02-08 BIIB Biogen Inc. Option Ex 2,765 .00 0
2013-02-09 BIIB Biogen Inc. Option Ex 4,692 .00 0
2012-02-23 BIIB Biogen Inc. Option Ex 4,281 .00 0
2012-02-09 BIIB Biogen Inc. Option Ex 4,692 .00 0
2012-02-01 BIIB Biogen Inc. Option Ex 21,400 55.53 1,188,449
2012-02-01 BIIB Biogen Inc. Sale 21,400 120.00 2,568,000
2012-01-03 BIIB Biogen Inc. Sale 20,244 112.46 2,276,559
2011-04-28 BIIB Biogen Inc. Sale 19,716 99.11 1,954,033
2011-04-28 BIIB Biogen Inc. Option Ex 14,766 43.24 638,481
2011-03-05 BIIB Biogen Inc. Option Ex 28,750 58.99 1,695,962
2011-02-23 BIIB Biogen Inc. Option Ex 3,521 .00 0
2008-09-19 BIIB Biogen Inc. Sale 1,553 50.00 77,650
2008-08-08 BIIB Biogen Inc. Sale 568 50.66 28,777
2008-07-01 BIIB Biogen Inc. Sale 4,208 56.01 235,677
2008-02-21 BIIB Biogen Inc. Sale 2,183 60.29 131,621
2008-02-12 BIIB Biogen Inc. Sale 958 60.99 58,428

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clancy Paul J (EVP, Chief Financial Officer of Alexion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.